Skip to main content
SpringerLink
Log in

Therapietreue in der oralen Tumortherapie

Adherence to oral anti-cancer therapy

  • Arzneimitteltherapiesicherheit
  • Published:
best practice onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Ludwig WD, Schwabe U (2016) Onkologika. In: Schwabe U, Paffrath D (Hrsg) Arzneiverordnungs-Report 2016. Springer, Berlin, Heidelberg, S 583

    Chapter  Google Scholar 

  2. Foulon V, Schoffski P, Wolter P (2011) Patient adherence to oral anticancer drugs: an emerging issue in modern oncology. Acta Clin Belg 66:85–96

    CAS  PubMed  Google Scholar 

  3. Weingart SN, Brown E, Bach PB et al (2008) NCCN task force report: oral chemotherapy. J Natl Compr Canc Netw 6(Suppl 3):1–14

    Google Scholar 

  4. World Health Organisation (2003) Adherence to long-term therapies: evidence for action. WHO, New York

    Google Scholar 

  5. Ryan R, Santesso N, Lowe D et al (2014) Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD007768.pub3

    Google Scholar 

  6. Lennecke K, Krolop L (2017) Adhärenzforschung. In: Jaehde U, Radziwill R, Kloft C (Hrsg) Klinische Pharmazie. Grundlagen und Anwendung, 4. Aufl. Wissenschaftliche Verlagsgesellschaft, Stuttgart, S 494–505

    Google Scholar 

  7. Bassan F, Peter F, Houbre B (2014) Adherence to oral antineoplastic agents by cancer patients: definition and literature review. Eur J Cancer Care (Engl) 23:22–35

    Article  CAS  Google Scholar 

  8. Unnikrishnan R, Veeraiah S, Mani S et al (2016) Comprehensive evaluation of adherence to therapy, its associations, and its implications in patients with chronic myeloid leukemia receiving Imatinib. Clin Lymphoma Myeloma Leuk 16:366–371

    Article  PubMed  Google Scholar 

  9. Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353:487–497

    Article  CAS  PubMed  Google Scholar 

  10. Zerillo JA, Goldenberg BA, Kotecha RR et al (2017) Interventions to improve oral chemotherapy safety and quality: a systematic review. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2017.0625

    Google Scholar 

  11. Deutsche Gesellschaft für Onkologische Pharmazie (2015) DGOP/DKG Initiative Orale Krebstherapie – Datenbank. http://www.dgop.org/ok_datenbank.html. Zugegriffen: 29. Juli 2017

    Google Scholar 

  12. Simons S, Ringsdorf S, Braun M et al (2011) Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care. Support Care Cancer 19:1009–1018

    Article  PubMed  Google Scholar 

  13. Krolop L, Ko YD, Schwindt PF et al (2013) Adherence management for patients with cancer taking capecitabine: a prospective two-arm cohort study. BMJ Open 3:e3139. https://doi.org/10.1136/bmjopen-2013-003139

    Article  PubMed  PubMed Central  Google Scholar 

  14. Krolop L (2013) Adherence Management for Cancer Patients on Capecitabine. Dissertation Rheinische Friedrich-Wilhelms-Universität Bonn

  15. Steinert A, Weddige J (2015) Therapietreue: Unterstützung per Smartphone-App. Dtsch Arztebl 112(10):4–5

    Google Scholar 

  16. Partridge AH, Avorn J, Wang PS et al (2002) Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 94:652–661

    Article  PubMed  Google Scholar 

  17. Simons S, Roth S, Jaehde U (2007) Non-Compliance: Therapietreue dauerhaft verbessern. Pharm Ztg 152:4348–4355

    Google Scholar 

  18. Mahler C, Hermann K, Horne R et al (2010) Assessing reported adherence to pharmacological treatment recommendations. Translation and evaluation of the Medication Adherence Report Scale (MARS) in Germany. J Eval Clin Pract 16:574–579

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmazeutisches Institut, Klinische Pharmazie, Rheinische Friedrich-Wilhelms-Universität Bonn, An der Immenburg 4, 53121, Bonn, Deutschland

    A. Barnert &  U. Jaehde

Authors
  1. A. Barnert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Jaehde
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to U. Jaehde.

Ethics declarations

Interessenkonflikt

A. Barnert und U. Jaehde geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren. Für die zitierten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Barnert, A., Jaehde, U. Therapietreue in der oralen Tumortherapie. best practice onkologie 12, 278–283 (2017). https://doi.org/10.1007/s11654-017-0043-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11654-017-0043-9

Search

Navigation